2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Cancer Imaging
Cancer imaging plays a pivotal role in modern oncology, revolutionizing how we detect, diagnose, and monitor cancer. Advanced techniques like MRI, CT scans, PET scans, and molecular imaging provide intricate details of tumors, aiding in early detection and precise treatment planning. Emerging technologies such as radiomics and artificial intelligence further enhance diagnostic accuracy by analyzing imaging data to identify subtle patterns indicative of cancer presence, subtype, and aggressiveness. Moreover, targeted imaging agents enable visualization of specific molecular pathways, offering insights into tumor biology and treatment response. The integration of imaging modalities with other disciplines like genomics and immunology is fostering a comprehensive understanding of cancer, driving personalized treatment strategies and improving patient outcomes. As technology advances, cancer imaging continues to evolve, promising even greater precision, sensitivity, and utility in the fight against cancer.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China